Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Business Wire•03/11/2026•08:03 ET
0
Key Highlights
- ➤Alto Neuroscience (ANRO) will participate in Stifel’s 2026 Healthcare Conference.
- ➤Stifel presentation scheduled for November 11 at 8:00 AM ET.
- ➤Alto will participate in the Jefferies London Healthcare Conference.
- ➤Jefferies presentation scheduled for November 19 at 9:30 AM GMT.
- ➤ALTO-207 is in late-stage clinical development for treatment-resistant depression.
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences:
Get started
Create a free account to read the full story.